VR Logo

Unrated

Mirae Asset Healthcare Fund - Regular Plan download report


1 Lakh

Investment Grown to
₹ 2.03 Lakh

₹ 10000

Monthly SIP Grown to
₹ 4.79 Lakh

Suitability:

This is a fund that invests mainly in shares of pharmaceutical and healthcare companies.

We believe that investors should avoid funds that have a narrowly defined investment mandate such as this one. Instead, they should invest in flexi-cap funds which provide complete freedom to the fund management team to invest in companies from which it expects maximum gains.

But if you do invest, you must do so only through the SIP route. Click here to read a primer on SIP investing.

Warning: Do not invest in this, or any other pharma sector fund, if you need to redeem your investment in less than seven years.

Taxability of earnings:

Capital gains

  • If the mutual fund units are sold after 1 year from the date of investment, gains upto Rs 1 lakh in a financial year are exempt from tax. Gains over Rs 1 lakh are taxed at the rate of 10%.
  • If the mutual fund units are sold within 1 year from the date of investment, entire amount of gain is taxed at the rate of 15%.
  • No tax is to be paid as long as you continue to hold the units.

Dividends

  • Dividends are added to the income of the investors and taxed according to their respective tax slabs. Further, if an investor's dividend income exceeds Rs. 5,000 in a financial year, the fund house also deducts a TDS of 10% before distributing the dividend.

Read more

ajax-loader
Please wait...

ajax-loader
Please wait...

(₹)
cal
cal

ajax-loader
Please wait...

Trailing Returns (%)

YTD 1-Day 1-W 1-M 3-M 6-M 1-Y 3-Y 5-Y 7-Y 10-Y
Mirae Asset Healthcare Fund Reg-G -15.36 1.36 -2.69 -10.18 -9.32 -11.54 -3.82 26.52 -- -- --
S&P BSE Healthcare TRI -14.64 1.47 -2.59 -10.31 -8.33 -11.07 -7.94 19.65 -- -- --
Equity: Sectoral-Pharma -14.00 1.44 -2.39 -9.63 -7.94 -10.89 -7.24 22.86 -- -- --
Rank within category 13 7 12 10 13 9 1 1 -- -- --
Number of funds in category 14 14 14 14 14 14 9 8 4 3 3

As on 13-May-2022

Peer Comparison

Fund name Rating Launch Date 1-Year Return 3-Year Return 5-Year Return Expense Ratio Assets (Cr)
Mirae Asset Healthcare Fund - Regular Plan  | Invest Online
Unrated
Jul-18 -3.82 26.52 -- 2.05% 1,790
Nippon India Pharma Fund
Unrated
Jun-04 -7.54 23.28 15.44 1.78% 4,851
ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund  | Invest Now
Unrated
Jul-18 -7.86 23.44 -- 2.36% 2,392
SBI Healthcare Opportunities Fund  | Invest Online
Unrated
Jul-99 -9.30 21.06 9.37 2.13% 1,763
DSP Healthcare Fund - Regular Plan  | Invest Online
Unrated
Nov-18 -4.67 26.42 -- 2.17% 1,270

Best & Worst Performance

Best Performance Worst Performance
Return (%) Period Return (%) Period
Week 19.80 01-Apr-2020 - 09-Apr-2020 -11.77 11-Mar-2020 - 18-Mar-2020
Month 36.07 23-Mar-2020 - 22-Apr-2020 -20.09 20-Feb-2020 - 23-Mar-2020
Quarter 47.13 23-Mar-2020 - 22-Jun-2020 -11.21 10-Feb-2022 - 12-May-2022
Year 89.95 23-Mar-2020 - 23-Mar-2021 -8.25 28-Aug-2018 - 28-Aug-2019

Risk Measures (%)

Mean Std Dev Sharpe Sortino Beta Alpha
Mirae Asset Healthcare Fund Reg-G 26.35 21.32 1.07 2.40 0.94 6.62
S&P BSE Healthcare TRI 20.70 22.26 0.77 1.54 -- --
Equity: Sectoral-Pharma 23.23 20.13 0.98 2.02 0.88 4.59
Rank within category 1 7 2 1 7 2
Number of funds in category 8 8 8 8 8 8

The Risk Measures have been calculated using calendar month returns for the last three years.

As on 30-Apr-2022

Asset Allocation (%)

ajax-loader
Please wait...

Concentration & Valuation

Number of Stocks 28
Top 10 Stocks (%) 66.37
Top 5 Stocks (%) 45.47
Top 3 Sectors (%) 98.76
Portfolio P/B Ratio 4.67
Portfolio P/E Ratio 34.52

Portfolio Aggregates

Fund Category
Average Mkt Cap (Rs Cr) 48,585 58,227
Giant (%) 16.16 19.29
Large (%) 40.35 37.16
Mid (%) 40.10 37.19
Small (%) 3.39 6.71
Tiny (%) -- 0.73

Value Research Fund Style

Sector Allocation vis-à-vis Category

ajax-loader
Please wait...

Top Holdings

Company Sector P/E 3Y High 3Y Low % Assets
equal Sun Pharmaceutical Industries Healthcare 33.06 16.17 9.54 16.17
down Dr. Reddy's Lab Healthcare 24.42 12.08 7.46 8.79
equal Cipla Healthcare 30.01 9.17 4.26 7.74
down Apollo Hospitals Healthcare 46.32 8.70 0.00 7.25
equal Torrent Pharmaceuticals Healthcare 35.69 7.24 3.02 5.52
equal Ipca Laboratories Healthcare 27.12 8.33 3.84 5.04
down Divi's Laboratories Healthcare 44.30 10.44 4.18 4.22
down Fortis Healthcare Healthcare 34.56 4.50 0.00 3.98
up Aurobindo Pharma Healthcare 11.21 6.40 1.78 3.88
up Gland Pharma Healthcare 43.29 3.78 0.00 3.78
equal JB Chemicals & Pharma Healthcare 30.92 3.50 0.00 3.50
equal Krishna Institute Of Medical Sciences Healthcare 50.07 3.42 0.00 3.37
equal Lupin Healthcare -- 5.66 3.05 3.09
equal Ajanta Pharma Healthcare 20.41 4.77 2.35 3.03
equal Natco Pharma Healthcare 47.06 4.07 0.63 2.63
equal Vinati Organics Chemicals 57.38 4.64 1.37 2.28
equal Alkem Laboratories Healthcare 20.72 3.56 1.57 2.12
equal Biocon Healthcare 59.56 6.83 1.88 2.10
equal Laurus Labs Healthcare 34.96 4.40 0.00 2.02
equal Tatva Chintan Pharma Chem Chemicals 48.07 1.89 0.00 1.89
equal ICICI Lombard General Insurance Company Insurance 50.33 2.00 0.00 1.70
equal Tarsons Products Healthcare 47.80 1.50 0.00 1.50
equal SBI Life Insurance Company Insurance 69.76 2.06 0.00 1.36
equal Max Financial Services Financial 96.70 2.32 0.88 1.28
equal Dr. Lal Pathlabs Healthcare 49.55 4.76 1.25 1.26

up down equal Indicates an increase or decrease or no change in holding since last portfolio
new Indicates a new holding since last portfolio

As on 30-Apr-2022

Fund Manager

— Vrijesh Kasera since 11-Jun-2018

Education: Mr. Kasera is a MBA (Finance), CFA (ICFAI).

Experience: Prior to joining Mirae Asset Mutual Fund, he was associated with Axis Capital Ltd. as an Equity Research Analyst. He has also been associated with Edelweiss Broking Ltd.

Funds Managed:


1.36%

Change from previous, NAV as on 13-May-2022

Growth: ₹ 20.3500

IDCW: ₹ 18.7000


Investment Strategy

The scheme seeks to generate long term capital appreciation through investing in equity and equity related securities of companies benefitting directly or indirectly in Healthcare and allied sectors in India.

Investment Details

Min. Investment (₹) 5,000
Min. Addl Investment (₹) 1,000
Min. SIP Investment (₹) 1,000
Min. No of Cheques 5
Min. Withdrawal (₹) --
Min. Balance (₹) --
Lock-in Period Not Applicable
Exit Load 1% for redemption within 365 days

Basic Details

Fund House: Mirae Asset Mutual Fund
Launch Date: 02-Jul-2018
Return Since Launch: 20.18%
Benchmark: S&P BSE Healthcare TRI
Riskometer: Very High
Type: Open-ended
Assets: ₹ 1,790 Cr (As on 30-Apr-2022)
Expense: 2.05% (As on 30-Apr-2022)
Risk Grade: --
Return Grade: --
Turnover: 24.00%

Most Recent Dividends

Plan Record Date Dividend (₹ / Unit)  
IDCW22-Mar-20221.8000

Contact Information

AMC: Mirae Asset Investment Managers (India) Pvt. Ltd.

Address: Unit No.606 - 6th Floor, Windsor Building - Off. CST Road, Kalina, Santacruz (East), Mumbai - 400098

Phone: 022-67800301 / 1800-2090-777

Website: http://www.miraeassetmf.co.in

Registrar & Transfer Agent: KFin Technologies Ltd.

Address: 303, Vamsee Estates, Opp. Big Bazaar, Ameerpet, Hyderabad - 500016

Phone: 040-44857874

Email: [email protected]

Website: www.karvymfs.com

Upcoming Video

Investors' Hangout

How safe are mutual funds?

DateFriday, 20-May-2022
Time12:30 PM - 12:40 PM

attending You have reserved a spot